On Wednesday, Nifty 50 rose 0.29% to 24,770.20. 37 stocks gained while 13 declined.
Divi’s Laboratories outshone its peers with a 3.76% increase to ₹4900.80. Divi’s gained after a U.S. court stayed the Food and Drug Administration’s (FDA) approval of the generic version of Entresto drug.
Titan also showed a strong performance, surging 2.46% to ₹3560.40. Other notable gainers included SBI Life Insurance, Cipla, and HDFC Life Insurance, all posting notable gains of 2.23%, 2.03% and 1.96%.
See Also: HUDCO And YEIDA Join Hands To Boost Development Projects Along Yamuna Expressway
Top Gainers:
Stock | Current Price | Last Close | % Change |
---|---|---|---|
Divi’s Laboratories | ₹4900.80 | ₹4723.15 | 3.76% |
Titan | ₹3560.40 | ₹3474.90 | 2.46% |
SBI Life Insurance | ₹1800.60 | ₹1761.30 | 2.23% |
Cipla | ₹1594.60 | ₹1562.85 | 2.03% |
HDFC Life Insurance | ₹724.55 | ₹710.60 | 1.96% |
Top Losers:
Stock | Current Price | Last Close | % Change |
---|---|---|---|
Tech Mahindra | ₹1604.65 | ₹1628.60 | -1.47% |
UltraTech Cement | ₹11200.90 | ₹11349.70 | -1.31% |
Tata Steel | ₹151.92 | ₹153.93 | -1.31% |
Power Grid Corporation of India | ₹336.65 | ₹340.50 | -1.13% |
Oil and Natural Gas Corporation | ₹327.70 | ₹330.10 | -0.73% |
On the other hand, Tech Mahindra experienced the largest drop with a 1.47% decline, with other significant decreases seen in stocks like UltraTech Cement, Tata Steel, Power Grid Corporation of India, and Oil and Natural Gas Corporation.
Vinod Nair, Head of Research, at Geojit Financial Services said, “The Indian market traded on a tight range with a positive bias supported by strong DII flows. While defensive sector outperformed due to a continued shift in portfolio towards FMCG, consumer, commodities, and pharma. Global markets exhibited a mildly cautious tone ahead of the release of the FOMC minutes later today. Currently, the expectation of a rate cut remains high, given the fall in US inflation and moderation in overall growth.”
Read Next: RVNL Signs MoU With Dhaya Maju Infrastructure To Expand Into ASEAN Market
Engineered by Benzinga Neuro, Edited by Ananthu CU
The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.
Don't miss a beat on the share market. Get real-time updates on top stock movers and trading ideas on Benzinga India Telegram channel.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.